Do not Give Antihistamines and Decongestants for Otitis Media in Children
Antihistamines and decongestants are often given to children with otitis media, even though there is no scientific evidence to support this. Otitis media is one of the most common causes of pediatric patient visits to the doctor. Approximately 50–85% of children will experience at least one episode of acute otitis media by the age of 3 years.
Acute otitis media (AOM) and otitis media with
effusion (OME) are 2 different types of otitis media. Although this disease is
common, the exact definition of AOM is still not understood by clinicians. AOM
is characterized by 3 components, namely acute onset within 48 hours, fluid in
the middle ear, and clinical manifestations such as otalgia, fever, and
hyperemic tympanic membrane.
OME is characterized by fluid in the middle
ear without acute inflammation, which can trigger or be followed by AOM. OME is
the highest cause of hearing loss that occurs in childhood. [1,2]
In Indonesia, otitis media is more common in
rural areas than urban areas, with the majority of cases occurring under the
age of 3 years. A study in Indonesia examined 7,005 children aged 6–15 years
and found that the prevalence of AOM was 5 cases per 1,000 people and the
prevalence of OME was 4 cases per 1,000 people. [3]
Hypothesis of the Role of Antihistamines
and Decongestants for Otitis Media in Children
The cause of OME in children is still not
known with certainty. Several theories have proposed the hypothesis that
inflammation of the rhinopharyngeal infection, mucosal biofilm formation,
gastroesophageal reflux, and allergy are the causes of OME. The high prevalence
of otitis media in children can also be caused by ear anatomy, namely the
immaturity of the child's Eustachian tube in terms of angle, length, and ability
to close. [4]
It was the course of the disease that
initially sparked the possible potential of antihistamines and decongestants in
the treatment of otitis media. Decongestants are thought to reduce mucosal
edema at the mouth of the Eustachian tube and fluid in the middle ear.
Both viruses and bacteria can produce
histamine, so the administration of antihistamines is expected to reduce the
inflammatory response and congestion of the mucous membranes, which is then
expected to reduce the duration of otitis media. [5,6]
Antihistamines and Decongestants Efficacy
for Otitis Media in Children
Despite the hypothesized potency of
antihistamines and decongestants, various clinical trials conducted in the last
30 years have shown that neither drug is effective against otitis media with
effusion in children. [5]
A Canadian study investigated the efficacy of
a single decongestant, pseudoephedrine, in children with OME and compared it
with placebo. The proportion of resolution of tympanic membrane inflammation
was not significantly different between the two groups. [1]
A Cochrane review by Griffin et al also
examined 16 randomized controlled trials with 1,800 subjects and compared
decongestant and placebo administration in children with OME. Study results did
not demonstrate any benefit in resolution of signs and symptoms of OME at 1
month. [2]
Similarly, studies examining the use of a
combination of the two drugs. The combination of antihistamines and
decongestants has shown no benefit in children with OME. Several studies have
shown that taking antihistamines alone has a negative impact on patients with
otitis media. [1]
Although there is no evidence of benefit from
antihistamines and decongestants in children with otitis media, several
investigators have reviewed that both agents have potential in otitis media
involving allergies. However, this is only supported by studies conducted on
animals, not humans. [1,2,6]
Side Effects of Antihistamines and
Decongestants in Children
Significant rates of adverse events have been reported
from the use of antihistamines and/or decongestants in children with OME. Side
effects that arise in the form of sedation, irritability, and gastrointestinal
disturbances.
In the use of decongestants, such as
phenylephrine and pseudoephedrine, the side effect rates in children with OME
were 24% and 6%, respectively. A UK study of children aged 3–10 years reported
that 12 children experienced side effects related to decongestant drug
withdrawal. Nine out of 12 children who take pseudoephedrine experience bad
emotions, irritability, dizziness, malaise, and sleep disturbances. [1]
Meanwhile, antihistamines, such as
chlorpheniramine maleate, are known to prolong the duration of middle ear
effusion. This is due to the anticholinergic potential of antihistamines as
well as a decrease in mucociliary function which can interfere with the
function of the Eustachian tube. Antihistamines are also thought to impair the
function of the secretory cells of the middle ear, affecting fluid drainage and
absorption, and leading to an increase in the viscosity of the middle ear fluid.
[1]
However, these side effects were found to
occur less frequently with the use of type 2 antihistamines, such as
cetirizine, because they have no anticholinergic activity and cannot cross the
blood-brain barrier. [1]
The same thing was conveyed in the Cochrane
review conducted by Griffin et al. There is no evidence of benefit from therapy
with antihistamines, decongestants, or a combination of the two in patients
with OME. Instead, there was an increase in the side effects of both drugs in
patients. These results are consistent from the various studies reviewed. [2]
Guidelines for the Management of Otitis
Media in Children
The American Academy of Otolaryngology (AAO) –
Head and Neck Surgery Foundation and Internal consensus (ICON) issued strong
recommendations against using antihistamines, decongestants, or both for the
management of otitis media. These recommendations aim to reduce ineffective
interventions, prevent the risk of side effects, and reduce the burden of
treatment costs. [7,8]
This is also in line with the guidelines of
the Canadian Pediatric Society. Recent guidelines from the American Academy of
Pediatrics on the management of otitis media do not even mention antihistamines
and decongestants for the treatment of otitis media. [9,10]
Conclusion
Various studies have concluded that
antihistamines and decongestants are not recommended as therapy for otitis media
in children. This is in line with the recommendations of several related
associations that do not recommend the administration of these two agents for
otitis media in children.
References
1. Bonney AG, Goldman RD.
Antihistamines for children with otitis media. Canadian Family Physician. 2014
Jan;60(1):43.
2. Griffin G, Flynn CA.
Antihistamines and/or decongestants for otitis media with effusion (OME) in
children. Cochrane Database Syst Rev. 2011;2011(9):CD003423. Published 2011 Sep
7. doi:10.1002/14651858.CD003423.pub3
3. Anggraeni R, Hartanto WW,
Djelantik B, Ghanie A, Utama DS, Setiawan EP, et al. Otitis media in indonesian
urban and rural school children. Pediatr Infect Dis J. 2014 Oct;33(10):1010–5.
4. Vanneste P, Page C. Otitis media
with effusion in children: Pathophysiology, diagnosis, and treatment. A review.
J Otol. 2019 Jun;14(2):33–9.
5. Principi N, Marchisio P, Esposito
S. Otitis media with effusion: benefits and harms of strategies in use for
treatment and prevention. Expert Review of Anti-infective Therapy. 2016 Apr
2;14(4):415–23.
6. Roditi RE, Caradonna DS, Shin JJ.
The Proposed Usage of Intranasal Steroids and Antihistamines for Otitis Media
with Effusion. Curr Allergy Asthma Rep. 2019 05;19(10):47.
7. Rosenfeld RM, Shin JJ, Schwartz
SR, Coggins R, Gagnon L, Hackell JM, et al. Clinical Practice Guideline: Otitis
Media with Effusion (Update). Otolaryngol Head Neck Surg. 2016
Feb;154(1_suppl):S1–41.
8. Simon F, Haggard M, Rosenfeld RM,
Jia H, Peer S, Calmels M-N, et al. International consensus (ICON) on management
of otitis media with effusion in children. Eur Ann Otorhinolaryngol Head Neck
Dis. 2018 Feb;135(1S):S33–9.
9. Forgie S, Zhanel G, Robinson J. Management of acute otitis media. Paediatr Child Health. 2009;14(7):457–64.
10. Diagnosis and Management of Acute
Otitis Media | American Academy of Pediatrics [Internet]. [cited 2020 Oct 18].
Available from:
https://pediatrics.aappublications.org/content/113/5/1451/tab-article-info
Tidak ada komentar: